Search Orphan Drug Designations and Approvals
-
Generic Name: | Telacebec |
---|---|
Date Designated: | 01/13/2021 |
Orphan Designation: | Treatment of Buruli ulcer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Qurient Co., Ltd. C-dong 8th Floor 242, Pangyo-ro, Bundang-gu, Seongnam-si Gyeonggi-do, Korea 463-400 South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
-